Evidence map›Paper›PMID 37099061›Full record

ArticleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2023

Long noncoding RNA HOTAIR promotes breast cancer development through the lncRNA HOTAIR/miR-1/GOLPH3 axis.

Jiawen Zhao, Lei Zhang, Yingzhu Zhao, Nan Wu, Xi Zhang, Rong Guo, Huimeng Li, Chunxiang Li, Kai Zheng, Dequan Liu and 1 more

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Potential regulatory role of the mActa biochimica et biophysica Sinica · 2025
    Review
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Jiawen Zhao *Department of Breast Surgery, The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Kunming, China.
Lei Zhang *Department of Breast Surgery, The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Kunming, China.
Yingzhu Zhao *Department of Breast and Thyroid Surgery, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
Nan Wu *Department of Medical School, Yunnan College of Business Management, Kunming, China.
Xi ZhangDepartment of Clinical Laboratory, Yunnan Cancer Hospital, Kunming, China.
Rong GuoDepartment of Breast Surgery, The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Kunming, China.
Huimeng LiSecond Department of General Surgery, Southern Central Hospital of Yunnan Province, The First People's Hospital of Honghe State, Honghe Hospital Affiliated to Kunming Medical University, Mengzi, Honghe, China.
Chunxiang LiDepartment of Breast Surgery, The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Kunming, China.
Kai ZhengDepartment of Breast Surgery, The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Kunming, China. Zhengkai1003@yeah.net.
Dequan LiuDepartment of Breast Surgery, The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Kunming, China. liu_dequan2018@126.com.
Shicong TangDepartment of Breast Surgery, The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Kunming, China. tang_shicong@126.com.ORCID http://orcid.org/0000-0002-0666-5172
Kunming Medical University · CNThe People's Hospital of Guangxi Zhuang Autonomous Region · CN

Funding

Beijing Science And Technology Innovation Medical Development Foundation no. KC2021-JK-0044-6Innovative Research Group Project of the National Natural Science Foundation of China 81960517Innovative Research Group Project of the National Natural Science Foundation of China no. 81960542Science and Technology Project of Yunnan Provincial Science and Technology Department 202001AU070093Science and Technology Project of Yunnan Provincial Science and Technology Department 202201AY070001-169Science and Technology Project of Yunnan Provincial Science and Technology Department no.202001AU070053Yunnan Health Training Project of High Level Talents no.H-2019075
6 · The paper itself

Abstract

backgroundThe lncRNA HOTAIR is frequently overexpressed in breast cancer tissues and plays an important role in the development of breast cancer. Here, we investigated the effect of the lncRNA HOTAIR on the biological behaviour of breast cancer cells and its molecular mechanism.

methodsWe investigated the level of HOTAIR in breast cancer and its clinical pathological characteristics by bioinformatic methods. Then, we evaluated the effects of HOTAIR and miRNA-1 expression on the biological behaviour of breast cancer cells by qPCR, Cell Counting Kit-8 (CCK-8) assay, clonogenic assays, Transwell assay and flow cytometry for cell proliferation, invasion migration and apoptosis, and cell cycle analysis. Finally, the target genes of the lncRNA HOTAIR/miR-1/GOLPH3 regulatory axis were validated by luciferase reports.

resultsThe expression of HOTAIR in breast cancer tissues was significantly higher than that in normal breast tissues (P < 0.05). Silencing of HOTAIR suppressed cell proliferation, invasion and migration, promoted apoptosis and induced G

conclusionsThe expression of HOTAIR was significantly elevated in breast cancer tissues. Reducing the expression of HOTAIR inhibited the proliferation, invasion and migration of breast cancer cells and promoted apoptosis, and the mechanism was mainly the effect of the lncRNA HOTAIR/miR-1/GOLPH3 regulatory axis on the biological behaviour of breast cancer cells.

Indexed as

Breast NeoplasmsMicroRNAsRNA, Long NoncodingApoptosisCell Line, TumorCell MovementCell ProliferationFemaleGene Expression Regulation, NeoplasticHumansLuciferasesMembrane ProteinsGOLPH3 protein, humanLuciferasesMembrane ProteinsMicroRNAsMIRN1 microRNA, humanRNA, Long NoncodingBreast cancerHOTAIRMigrationmiRNA-1Proliferation

Identifiers

PMID37099061
OpenAlexW4367048113

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.